Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Philip W. Iversen"'
Autor:
Rikke B. Holmgaard, David A. Schaer, Yanxia Li, Stephen P. Castaneda, Mary Y. Murphy, Xiaohong Xu, Ivan Inigo, Julie Dobkin, Jason R. Manro, Philip W. Iversen, David Surguladze, Gerald E. Hall, Ruslan D. Novosiadly, Karim A. Benhadji, Gregory D. Plowman, Michael Kalos, Kyla E. Driscoll
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-15 (2018)
Abstract Background TGFβ signaling plays a pleotropic role in tumor biology, promoting tumor proliferation, invasion and metastasis, and escape from immune surveillance. Inhibiting TGFβ’s immune suppressive effects has become of particular intere
Externí odkaz:
https://doaj.org/article/add74ac3d1f847239e42c3dd99f9f142
Autor:
David A. Schaer, Richard P. Beckmann, Jack A. Dempsey, Lysiane Huber, Amelie Forest, Nelusha Amaladas, Yanxia Li, Ying Cindy Wang, Erik R. Rasmussen, Darin Chin, Andrew Capen, Carmine Carpenito, Kirk A. Staschke, Linda A. Chung, Lacey M. Litchfield, Farhana F. Merzoug, Xueqian Gong, Philip W. Iversen, Sean Buchanan, Alfonso de Dios, Ruslan D. Novosiadly, Michael Kalos
Publikováno v:
Cell Reports, Vol 22, Iss 11, Pp 2978-2994 (2018)
Summary: Abemaciclib, an inhibitor of cyclin dependent kinases 4 and 6 (CDK4/6), has recently been approved for the treatment of hormone receptor-positive breast cancer. In this study, we use murine syngeneic tumor models and in vitro assays to inves
Externí odkaz:
https://doaj.org/article/1595454cd7fc4830988cdc917336d3e6
Autor:
Philip W. Iversen, Mervyn Marasinghe
Publikováno v:
Journal of Statistical Software, Vol 13, Iss 1, Pp 1-18 (2004)
The structure, or Hasse, diagram described by Taylor and Hilton (1981, American Statistician) provides a visual display of the relationships between factors for balanced complete experimental designs. Using the Hasse diagram, rules exist for determin
Externí odkaz:
https://doaj.org/article/090b8625ffe14431b7907b61a1346a09
Publikováno v:
Journal of Statistical Software, Vol 13, Iss 3 (2004)
Externí odkaz:
https://doaj.org/article/3e1c97d7e5a74bf59dd1cc63c511e8d1
Autor:
Sean G. Buchanan, James R. Henry, Robert M. Campbell, Christoph Reinhard, Gregory D. Plowman, David A. Barda, Xiang S. Ye, Hui-Rong Qian, Shaoyou Chu, Thompson Doman, Matthew Z. Dieter, Yu-Hua Hui, Scott W. Eastman, María José Lallena, Carmen Baquero, Carlos Marugán, Michele Dowless, Stephen R. Wasserman, Kenneth Weichert, Anna Pustilnik, Danalyn Manglicmot, Karen Froning, Ann M. Mc Nulty, Stephen Antonysamy, Avnish Kapoor, Li Fan, Chris Ficklin, Huimin Bian, Sufang Yao, Shaoling Jin, Bomie Han, Wayne Blosser, Xi Lin, Robert D. Van Horn, Li-Chun Chio, Philip W. Iversen, Yue Webster, Farhana F. Merzoug, Stephen H. Parsons, Jian Du, Xueqian Gong
LY3295668 chemical characterization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459c3119cab021ba3189b2c2e7d96d2e
https://doi.org/10.1158/2159-8290.22533034.v1
https://doi.org/10.1158/2159-8290.22533034.v1
Autor:
Sean G. Buchanan, James R. Henry, Robert M. Campbell, Christoph Reinhard, Gregory D. Plowman, David A. Barda, Xiang S. Ye, Hui-Rong Qian, Shaoyou Chu, Thompson Doman, Matthew Z. Dieter, Yu-Hua Hui, Scott W. Eastman, María José Lallena, Carmen Baquero, Carlos Marugán, Michele Dowless, Stephen R. Wasserman, Kenneth Weichert, Anna Pustilnik, Danalyn Manglicmot, Karen Froning, Ann M. Mc Nulty, Stephen Antonysamy, Avnish Kapoor, Li Fan, Chris Ficklin, Huimin Bian, Sufang Yao, Shaoling Jin, Bomie Han, Wayne Blosser, Xi Lin, Robert D. Van Horn, Li-Chun Chio, Philip W. Iversen, Yue Webster, Farhana F. Merzoug, Stephen H. Parsons, Jian Du, Xueqian Gong
shRNA suppressor screening data for H446 and MDA-MB-468 cells (tabs 1, 2) and RNA expression level associations with LY3295668 Abs IC50 values from 493 cancer cell lines (tab 3).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f7062b69c7f18848d7e882885812c96
https://doi.org/10.1158/2159-8290.22533025.v1
https://doi.org/10.1158/2159-8290.22533025.v1
Autor:
Sean G. Buchanan, James R. Henry, Robert M. Campbell, Christoph Reinhard, Gregory D. Plowman, David A. Barda, Xiang S. Ye, Hui-Rong Qian, Shaoyou Chu, Thompson Doman, Matthew Z. Dieter, Yu-Hua Hui, Scott W. Eastman, María José Lallena, Carmen Baquero, Carlos Marugán, Michele Dowless, Stephen R. Wasserman, Kenneth Weichert, Anna Pustilnik, Danalyn Manglicmot, Karen Froning, Ann M. Mc Nulty, Stephen Antonysamy, Avnish Kapoor, Li Fan, Chris Ficklin, Huimin Bian, Sufang Yao, Shaoling Jin, Bomie Han, Wayne Blosser, Xi Lin, Robert D. Van Horn, Li-Chun Chio, Philip W. Iversen, Yue Webster, Farhana F. Merzoug, Stephen H. Parsons, Jian Du, Xueqian Gong
Supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071e82c7fa2f25274a31dc41f9817c55
https://doi.org/10.1158/2159-8290.22533037
https://doi.org/10.1158/2159-8290.22533037
Autor:
Sheng-Bin Peng, Gregory D. Plowman, Ramon V. Tiu, James R. Henry, Amit Aggarwal, Jason C. Ting, Steven Bray, Philip Ebert, Yue Wang Webster, Ruslan D. Novosiadly, Amelie Forest, Robert D. Van Horn, Youyan Zhang, Philip W. Iversen, Gregory P. Donoho, Yung-mae M. Yao
Purpose: To evaluate the antitumor efficacy of cetuximab in combination with LSN3074753, an analog of LY3009120 and pan-RAF inhibitor in 79 colorectal cancer patient-derived xenograft (PDX) models.Experimental Design: Seventy-nine well-characterized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92cd051fadba964dc0ea8b343c15323d
https://doi.org/10.1158/1078-0432.c.6527070
https://doi.org/10.1158/1078-0432.c.6527070
Autor:
Sheng-Bin Peng, Gregory D. Plowman, Ramon V. Tiu, James R. Henry, Amit Aggarwal, Jason C. Ting, Steven Bray, Philip Ebert, Yue Wang Webster, Ruslan D. Novosiadly, Amelie Forest, Robert D. Van Horn, Youyan Zhang, Philip W. Iversen, Gregory P. Donoho, Yung-mae M. Yao
S1 and S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b3a64c2b4999a7e270e5e94117a9f5
https://doi.org/10.1158/1078-0432.22468845.v1
https://doi.org/10.1158/1078-0432.22468845.v1
Autor:
Louis F. Stancato, Malcolm A. Smith, Beverly A. Teicher, Stephen W. Erickson, C. Patrick Reynolds, Min H. Kang, E. Anders Kolb, Richard Gorlick, Peter J. Houghton, Raushan T. Kurmasheva, Brian P. Rubin, Douglas S. Hawkins, John M. Maris, Kristina A. Cole, Kateryna Krytska, Richard P. Beckmann, Aimee Bence Lin, Philip W. Iversen, Jennifer R. Stephens, Alle B. VanWye, Wayne Blosser, Matthew Renschler, Michele Dowless, Caitlin D. Lowery
Purpose:Checkpoint kinase 1 (CHK1) inhibitors potentiate the DNA-damaging effects of cytotoxic therapies and/or promote elevated levels of replication stress, leading to tumor cell death. Prexasertib (LY2606368) is a CHK1 small-molecule inhibitor und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68f49e5209cc968b1be0066c56c47cfe
https://doi.org/10.1158/1078-0432.c.6528686
https://doi.org/10.1158/1078-0432.c.6528686